ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VKTX Viking Therapeutics Inc

81.60
-1.74 (-2.09%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 4,331,410
Bid Price 81.60
Ask Price 81.85
News -
Day High 84.70

Low
8.28

52 Week Range

High
99.3999

Day Low 80.50
Company Name Stock Ticker Symbol Market Type
Viking Therapeutics Inc VKTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.74 -2.09% 81.60 19:59:39
Open Price Low Price High Price Close Price Prev Close
83.50 80.50 84.70 82.00 83.34
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
52,887 4,331,410 $ 82.65 $ 357,974,179 - 8.28 - 99.3999
Last Trade Time Type Quantity Stock Price Currency
19:59:18 1 $ 81.90 USD

Viking Therapeutics (VKTX) Options Flow Summary

Overall Flow

Bullish

Net Premium

5M

Calls / Puts

593.75%

Buys / Sells

106.25%

OTM / ITM

38.75%

Sweeps Ratio

0.01%

Viking Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8.23B 100.49M - 0 -85.9M -0.85 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Viking Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VKTX Message Board. Create One! See More Posts on VKTX Message Board See More Message Board Posts

Historical VKTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week71.9789.099768.688578.676,904,6899.6313.38%
1 Month90.4996.7460.48576.379,049,152-8.89-9.82%
3 Months17.4699.399917.3663.796,755,48364.14367.35%
6 Months10.9999.39998.2849.104,444,49170.61642.49%
1 Year12.3199.39998.2835.243,961,56769.29562.88%
3 Years6.1499.39992.0223.592,200,44375.461,228.99%
5 Years8.4099.39992.0218.461,914,33373.20871.43%

Viking Therapeutics Description

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Your Recent History

Delayed Upgrade Clock